Octreotid-Mepha LA 20 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
7680671540024
CH-67154
Pulver
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
octreotidum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
carmellosum natricum
|
- | Substance | HNIDK |
|
natrium
|
1.512 MG | Substance | HBESI |
|
octreotidi acetas
|
- | Substance | WIZUS |
|
poly(lactidum-co-glycolidum)
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
poloxamerum 188
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67154
- Drug name
- Octreotid-Mepha LA, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension
- Galenic form
- PULMS
- ATC Code
- H01CB02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 19/07/2019
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.2.
- Domain
- Human medicine
Package details
- Description (FR)
- OCTREOTID Mepha LA subst sèche 20 mg c solv
- Description (DE)
- OCTREOTID Mepha LA Trockensub 20 mg c Solv
- Narcotic (BTM)
- No
Available generics (4)
Octreotid Labatec 0.2 mg/ml, Solution pour injection
GTIN: 7680651100019
CHF 92.05
Octreotid Labatec, Solution pour injection
GTIN: 7680632410014
CHF 38.15
Octreotid Labatec, Solution pour injection
GTIN: 7680632410021
CHF 56.90
Octreotid Labatec, Solution pour injection
GTIN: 7680632410038
CHF 239.35